Greater than 90% of physicians using iKnowMed successfully attested to Meaningful Use in 2013 and earned more than $28 million in combined incentive payments since 2011
The Woodlands, Texas (May 31, 2014) — iKnowMedSM EHR (version 6.6.0), iKnowMed Generation 2
(version 2.0), and My Care PlusSM patient portal (version 3.0),
oncology-specific products of McKesson Specialty Health,
are all “Meaningful Use-ready” and have received 2014 Edition Complete EHR
Certification. Combining the advanced technology of McKesson Specialty Health
with expertise from physicians in The US Oncology Network, this oncology-specific suite of technology products provides
unique support for clinicians and their patients.
Tested and certified under the Drummond Group's
Electronic Health Records Office of the National Coordinator Authorized Certification
Body (ONC-ACB) program, iKnowMed EHR, iKnowMed Generation 2 and My Care Plus are
2014 Edition compliant in accordance with the criteria adopted by the Secretary
of Health and Human Services. Providers using certified EHR products can
demonstrate Meaningful Use in 2014 and beyond and qualify for incentive
payments while avoiding penalties under the American
Recovery and Reinvestment Act (ARRA).
“Our 2014 Edition Meaningful
Use certified products assist clinicians
in providing the most advanced care to their patients through increased patient
engagement, care coordination and clinical decision support,” said Jeffrey Kao,
chief information officer, McKesson Specialty Health. “By incorporating the
latest interoperability standards into our next generation healthcare
technology products, we
can improve information exchange with other
electronic systems that have and need
patient care details, including other EHR systems at collaborating practices
and hospitals.”
Providing excellent Meaningful Use
support for community-based oncology practices has been a top priority for the iKnowMed
EHR team. In 2013, greater than 90 percent of physicians using iKnowMed
successfully attested for Stage 1 Meaningful Use, earning them and their
practices more than $28 million in combined incentive dollars since 2011. To
help physicians and their staff meet Meaningful Use,
McKesson Specialty Health offers staff
support, project management tools and educational materials that assist users in
navigating needed workflow changes. As providers enter Stages 1 or 2 of
Meaningful Use in 2014, McKesson Specialty Health will continue to support
their users in meeting the heightened requirements.
“I am pleased with the support the
iKnowMed team provided to me and my practice. With their assistance, we were
able to meet Stage 1 requirements quickly and efficiently as well as maximize
the available incentives, benefiting the practice, but more importantly, our
patients,” said Yoosaf Abraham (Abe), chief operating officer, Cancer Center of
Kansas. “With the team’s support, I know we will be able to meet Stage 2
requirements and implement new technologies to benefit patients, including a
patient portal that will improve our ability to engage with patients online.”
To support users with heightened Stage 1 and 2 requirements that require providers
to engage patients digitally, iKnowMed EHR and iKnowMed Generation 2 users leverage
the My Care Plus patient portal, which currently provides more than 75,000 enrolled patients with secure, online access to their health records. The patient portal gives patients the ability to easily share information with their providers, caregivers and family members; plus, view lab results, send secure
messages to their providers and access educational resources specific to their
condition and treatment.
iKnowMed and iKnowMed Generation 2
were developed in collaboration with oncologists to meet the unique needs of
cancer patients and have been implemented in more than 550 sites of care
nationwide and used by 1,400 providers. iKnowMed Generation 2 builds upon the robust, oncology-specific electronic health
record features of iKnowMed, which was named the top ranked EHR for oncologists
and hematologists by Black Book Rankings for three consecutive years.
iKnowMed
EHR version 6.6.0 was certified on May 30, 2014. Certification ID number 05302014‐2325‐8. Modules tested and certified: 170.314(a)(1‐15);
170.314(b)(1‐5, 7); 170.314(c)(1‐3); 170.314(d)(1‐8);
170.314(e)(1‐3); 170.314(f)(1‐3, 5); 170.314(g)(2‐4).
Clinical Quality Measures tested and
certified: CMS002v3;
CMS068v3; CMS069v2; CMS126v2; CMS138v2; CMS147v2; CMS156v2; CMS157v2; CMS165v2. Additional software relied upon to certify: Surescripts Clinical
Interoperability.
iKnowMed Generation 2 version 2.0
was certified on May 30, 2014. Certification ID number 05302014‐2326‐8. Modules tested and certified: 170.314(a)(1‐15); 170.314(b)(1‐5,
7); 170.314(c)(1‐3);
170.314(d)(1‐8); 170.314(e)(1‐3);
170.314(f)(1‐3, 5); 170.314(g)(2‐4).
Clinical Quality Measures tested and certified: CMS002v3; CMS068v3; CMS069v2;
CMS126v2; CMS138v2; CMS147v2; CMS156v2; CMS157v2; CMS165v2. Additional software
relied upon to certify: NewCropRx, Surescripts Clinical Interoperability.
These Complete
EHRs are 2014 Edition compliant
and have been certified by an ONC‐ACB in accordance with the applicable certification
criteria adopted by the Secretary of the U.S. Department of Health and Human
Services. This certification does not represent an endorsement by the
U.S. Department of Health and Human Services or guarantee the receipt of
incentive payments.
McKesson
Specialty Health EHR and patient portal software services require a one-time
implementation fee for installation plus monthly subscription fees which cover
software licenses, customer support, software upgrades, and services required
to meet Meaningful Use objectives and measures. Interfaces or health
information exchange integration require additional implementation fees and
monthly subscription fees.
Learn more about iKnowMed Generation
2 and My Care Plus by visiting www.McKessonspecialtyhealth.com/iKnowMed.
About
McKesson Specialty Health
McKesson
Specialty Health, a division of McKesson Corporation, empowers the community
patient care delivery system by helping community practices advance the
science, technology and quality of care. Through innovative clinical, research,
business and operational solutions, facilitated by integrated technology
systems, we focus on improving the financial health of our customers so they
may provide the best care to their patients. For more information, visit www.McKessonspecialtyhealth.com.
About The US Oncology
Network
The US Oncology Network is one of the
nation’s largest networks of integrated, community-based oncology practices
dedicated to advancing high-quality, evidence-based cancer care. A physician-led
organization, The US Oncology Network unites like-minded physicians and
clinicians around a common vision of improving patient outcomes and quality of
life. Leveraging healthcare information technology, shared best practices,
evidence-based guidelines and quality measurements, physicians within The US
Oncology Network are pioneering new ways to achieve this vision. The US
Oncology Network is committed to strengthening patient access to integrated
care in local communities across the nation, including collaboration with a
variety of payers, hospitals and academic institutions. The US Oncology Network
is supported by McKesson Specialty Health,
a division of McKesson Corporation focused on
empowering a vibrant and sustainable community patient care delivery system.
For more information, visit www.usoncology.com.
About
Drummond Group Inc.
Drummond
Group Inc. is a global software test and
certification lab that serves a wide range of vertical industries. In
healthcare, Drummond Group tests and certifies Controlled Substance Ordering
Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS)
software and processes, and Electronic Health Records (EHRs) – designating the
trusted test lab as the only third-party certifier of all three initiatives
designed to move the industry toward a digital future. Founded in 1999, and
accredited for the Office of the National Coordinator HIT Certification Program
as an Authorized Certification Body (ACB) and an Accredited Test Lab (ATL), Drummond
Group continues to build upon its deep experience and expertise necessary to
deliver reliable and cost-effective services. For more information, please
visit http://www.drummondgroup.com or email DGI@drummondgroup.com.
PR Contact
Contact Public Relations